BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 16920640)

  • 1. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
    Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
    Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2.
    Mankodi A; Teng-Umnuay P; Krym M; Henderson D; Swanson M; Thornton CA
    Ann Neurol; 2003 Dec; 54(6):760-8. PubMed ID: 14681885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A putative role of ribonuclear inclusions and MBNL1 in the impairment of gallbladder smooth muscle contractility with cholelithiasis in myotonic dystrophy type 1.
    Cardani R; Mancinelli E; Saino G; Bonavina L; Meola G
    Neuromuscul Disord; 2008 Aug; 18(8):641-5. PubMed ID: 18653337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2.
    Cardani R; Baldassa S; Botta A; Rinaldi F; Novelli G; Mancinelli E; Meola G
    Neuromuscul Disord; 2009 May; 19(5):335-43. PubMed ID: 19345584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy.
    Hao M; Akrami K; Wei K; De Diego C; Che N; Ku JH; Tidball J; Graves MC; Shieh PB; Chen F
    Dev Dyn; 2008 Feb; 237(2):403-10. PubMed ID: 18213585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression.
    Margolis JM; Schoser BG; Moseley ML; Day JW; Ranum LP
    Hum Mol Genet; 2006 Jun; 15(11):1808-15. PubMed ID: 16624843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
    de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
    Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences.
    Sellier C; Cerro-Herreros E; Blatter M; Freyermuth F; Gaucherot A; Ruffenach F; Sarkar P; Puymirat J; Udd B; Day JW; Meola G; Bassez G; Fujimura H; Takahashi MP; Schoser B; Furling D; Artero R; Allain FHT; Llamusi B; Charlet-Berguerand N
    Nat Commun; 2018 May; 9(1):2009. PubMed ID: 29789616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats.
    Kino Y; Mori D; Oma Y; Takeshita Y; Sasagawa N; Ishiura S
    Hum Mol Genet; 2004 Mar; 13(5):495-507. PubMed ID: 14722159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (CCUG)
    Yenigun VB; Sirito M; Amcheslavky A; Czernuszewicz T; Colonques-Bellmunt J; García-Alcover I; Wojciechowska M; Bolduc C; Chen Z; López Castel A; Krahe R; Bergmann A
    Dis Model Mech; 2017 Aug; 10(8):993-1003. PubMed ID: 28623239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA pathogenesis of the myotonic dystrophies.
    Day JW; Ranum LP
    Neuromuscul Disord; 2005 Jan; 15(1):5-16. PubMed ID: 15639115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2.
    Mankodi A; Urbinati CR; Yuan QP; Moxley RT; Sansone V; Krym M; Henderson D; Schalling M; Swanson MS; Thornton CA
    Hum Mol Genet; 2001 Sep; 10(19):2165-70. PubMed ID: 11590133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of MBNL and CELF mRNA transcripts in muscles with myotonic dystrophy.
    Nezu Y; Kino Y; Sasagawa N; Nishino I; Ishiura S
    Neuromuscul Disord; 2007 Apr; 17(4):306-12. PubMed ID: 17331722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington's disease--like 2 is associated with CUG repeat-containing RNA foci.
    Rudnicki DD; Holmes SE; Lin MW; Thornton CA; Ross CA; Margolis RL
    Ann Neurol; 2007 Mar; 61(3):272-82. PubMed ID: 17387722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes.
    Cerro-Herreros E; Chakraborty M; Pérez-Alonso M; Artero R; Llamusí B
    Sci Rep; 2017 Jun; 7(1):2843. PubMed ID: 28588248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons.
    Jiang H; Mankodi A; Swanson MS; Moxley RT; Thornton CA
    Hum Mol Genet; 2004 Dec; 13(24):3079-88. PubMed ID: 15496431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
    Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA
    Hum Mol Genet; 2006 Jul; 15(13):2087-97. PubMed ID: 16717059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.
    Pascual M; Vicente M; Monferrer L; Artero R
    Differentiation; 2006 Mar; 74(2-3):65-80. PubMed ID: 16533306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.